This initiative, conducted at the Arthritis Center at Brigham and Women’s Hospital, had three distinct but related steps:
- Development of an internally endorsed treatment pathway.
- Detailed retrospective Chart reviews.
- Improved documentation of functional status and disease activity measures.
Citation for the Full-text Article
Dave AJ, Tory HO, Awosogba JA, Coblyn JS, Bermas B, Solomon DH, Desai SP. A quality improvement approach to rheumatoid Arthritis management with biologic disease-modifying antirheumatic drugs: assessing variability in a treatment pathway. J Clin Rheumatol. 2017 Jan;23(1):66-69. doi: 10.1097/RHU.0000000000000474.